# BIORA THERAPEUTICS, INC.

BIORA THERAPEUTICS, INC. is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** BIORA THERAPEUTICS, INC.
- **Former names in filing history:** PROGENITY, INC. (2015-06-17 to 2022-04-19); ASCENDANT MDX, INC. (2013-06-27 to 2013-06-28)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001580063

## About

BIORA THERAPEUTICS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001580063, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-04-01, it reported annual revenue of USD 4,000; net income of USD -124,115,000; total assets of USD 31,215,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $4,000 (USD 4,000)
- **Net income:** -$124.1M (USD -124,115,000)
- **Total assets:** $31.2M (USD 31,215,000)
- **Cash and equivalents:** $15.0M (USD 15,000,000)
- **Operating cash flow:** -$48.5M (USD -48,499,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $12.2M (USD 12,153,000)
- **Net income:** -$38.2M (USD -38,157,000)
- **Total assets:** $53.5M (USD 53,525,000)
- **Cash and equivalents:** $30.5M (USD 30,486,000)
- **Operating cash flow:** -$64.4M (USD -64,417,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $60.6M (USD 60,609,000)
- **Net income:** -$247.4M (USD -247,412,000)
- **Total assets:** $108.8M (USD 108,839,000)
- **Cash and equivalents:** $88.4M (USD 88,397,000)
- **Operating cash flow:** -$167.5M (USD -167,486,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $74.3M (USD 74,313,000)
- **Net income:** -$192.5M (USD -192,528,000)
- **Total assets:** $154.4M (USD 154,440,000)
- **Cash and equivalents:** $92.1M (USD 92,076,000)
- **Operating cash flow:** -$165.7M (USD -165,744,000)
- **Later filings:** Revenue, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2024-12-30 — period 2024-12-27 — CURRENT REPORT
- Form 8-K — filed 2024-12-10 — period 2024-12-10 — 8-K
- Form 8-K — filed 2024-11-15 — period 2024-11-13 — 8-K
- Form 10-Q — filed 2024-11-14 — period 2024-09-30 — 10-Q
- Form 8-K — filed 2024-11-14 — period 2024-11-14 — 8-K
- Form SC 13G — filed 2024-11-14
- Form 8-K — filed 2024-10-29 — period 2024-10-28 — 8-K
- Form DEF 14A — filed 2024-10-23 — period 2024-11-13 — DEF 14A
- Form 8-K — filed 2024-10-11 — period 2024-10-09 — 8-K
- Form 8-K — filed 2024-10-07 — period 2024-10-07 — 8-K
- Form DEF 14A — filed 2024-09-16 — period 2024-10-09 — DEF 14A
- Form 8-K — filed 2024-09-13 — period 2024-09-10 — 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/biora-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology